Julia Spode
Research Subjects
Julia Spode has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ana Flávia dos Santos Fuzaro
Departamento de Química, Universidade Federal de Juiz de Fora, São Pedro, Juiz de Fora - MG, 36036-900, Brazil
1 shared publication Bruno Vilsinski
1 shared publicationCaroline Raquel Bender
1 shared publicationFrederico Silva
1 shared publicationJacy Gameiro
1 shared publicationMaria de Paula Rodrigues
1 shared publication
Latest Publications
- Open Access
- 12 February 2026
- Published by Elsevier in SSRN Electronic Journal
Formulation of Tryptanthrin incorporated in Pluronic-based copolymers aiming biomedical purposes
The hydrophobicity of natural products is a challenge in medicinal chemistry, where there is a high demand for improving bioavailability to enable the clinical use of these compounds. Thus, this study investigated the potential of Pluronic-F127 and Pluronic-P123 as carrier systems for tryptanthrin (TRYP), a natural product with various biological properties, particularly its anticancer activity. Our research group synthesized TRYP and micelles using the solid dispersion method, which were characterized by UV-VIS, FTIR, DLS, TGA, and DSC techniques. The encapsulation efficiency of the formulated TRYP/F-127 and TRYP/P-123 was 76.10±1.20 and 75.36 ± 2.20%, respectively. The nanostructured system was effective in promoting the solubilization of TRYP in an aqueous medium. In vitro cellular viability was assessed against the MCF-7 cell line, showing that both formulations increased cytotoxicity against the tested tumor cells and are promising for bioapplication.
- 12 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFormulation of Tryptanthrin incorporated in Pluronic-based copolymers aiming biomedical purposes
The hydrophobicity of natural products is a challenge in medicinal chemistry, where there is a high demand for improving bioavailability to enable the clinical use of these compounds. Thus, this study investigated the potential of Pluronic-F127 and Pluronic-P123 as carrier systems for tryptanthrin (TRYP), a natural product with various biological properties, particularly its anticancer activity. Our research group synthesized TRYP and micelles using the solid dispersion method, which were characterized by UV-VIS, FTIR, DLS, TGA, and DSC techniques. The encapsulation efficiency of the formulated TRYP/F-127 and TRYP/P-123 was 76.10±1.20 and 75.36 ± 2.20%, respectively. The nanostructured system was effective in promoting the solubilization of TRYP in an aqueous medium. In vitro cellular viability was assessed against the MCF-7 cell line, showing that both formulations increased cytotoxicity against the tested tumor cells and are promising for bioapplication.